Is EMBCV or DGRO a better dividend investment in 2026?

EMBCV currently yields 6.00% with a 5% 5-year dividend growth rate. DGRO yields 2.10% with 9.5% growth. The better choice depends on your goal: EMBCV offers higher current income.

What is the dividend yield difference between EMBCV and DGRO?

EMBCV has a forward dividend yield of 6.00% ($2.00/share annually). DGRO yields 2.10% ($1.47/share annually). The yield gap is 3.90 percentage points.

Home › Compare › EMBCV vs DGRO

EMBCV vs DGRO: Dividend Comparison 2026

EMBCV yields 6.00% · DGRO yields 2.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DGRO wins by $1.8K in total portfolio value· pulled ahead in Year 3

INVESTMENT

TIME HORIZON10 years

EMBCV

● Live price

6.00%

Share price

$33.33

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.7K

Annual income

$879.62

Full EMBCV calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.10%

Share price

$70.18

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$235.38

Full DGRO calculator →

Portfolio growth — EMBCV vs DGRO

📍 DGRO pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EMBCV	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EMBCV + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EMBCV pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMBCV

Annual income on $10K today (after 15% tax)

$510.05/yr

After 10yr DRIP, annual income (after tax)

$747.68/yr

DGRO

Annual income on $10K today (after 15% tax)

$178.14/yr

After 10yr DRIP, annual income (after tax)

$200.07/yr

At 15% tax rate, EMBCV beats the other by $547.60/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMBCV + DGRO for your $10,000?

EMBCV: 50%DGRO: 50%

100% DGRO50/50100% EMBCV

Portfolio after 10yr

$30.6K

Annual income

$557.50/yr

Blended yield

1.82%

📊

Analyst Conviction Gap

Where Wall Street is split right now

EMBCV

Analyst Ratings

Hold

Consensus: Hold

Price Target

$36.00

+8.0% upside vs current

Range: $36.00 — $36.00

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMBCV buys

DGRO buys

No recent congressional trades found for EMBCV or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEMBCVDGRO

Forward yield	6.00% ✓	2.10%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$29.7K	$31.6K ✓
Annual income after 10y	$879.62 ✓	$235.38
Total dividends collected	$7.4K ✓	$2.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EMBCV vs DGRO ($10,000, DRIP)

Year	EMBCV Portfolio	EMBCV Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1	$11,300	$600.06	$11,290	$209.57	+$10.00 → EMBCV
2	$12,725	$633.71	$12,722	$213.54	+$3.00 → EMBCV
3← crossover	$14,282	$666.93	$14,314	$217.18	$32.00 → DGRO
4	$15,982	$699.59	$16,080	$220.53	$98.00 → DGRO
5	$17,832	$731.62	$18,040	$223.59	$208.00 → DGRO
6	$19,843	$762.92	$20,215	$226.40	$372.00 → DGRO
7	$22,026	$793.43	$22,627	$228.96	$601.00 → DGRO
8	$24,391	$823.07	$25,302	$231.31	$911.00 → DGRO
9	$26,950	$851.82	$28,268	$233.44	$1.3K → DGRO
10	$29,716	$879.62	$31,557	$235.38	$1.8K → DGRO

EMBCV vs DGRO: Complete Analysis 2026

EMBCV — Stock

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.

Full EMBCV Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this EMBCV vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMBCV vs SCHD EMBCV vs JEPI EMBCV vs O EMBCV vs KO EMBCV vs MAIN EMBCV vs VIG EMBCV vs NOBL EMBCV vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.